Eyenovia, Inc. (EYEN): Price and Financial Metrics
Eyenovia, Inc. (EYEN)
Today's Latest Price: $3.63 USD
Updated Nov 27 1:00pm
Add EYEN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
EYEN Stock Price Chart Interactive Chart >
EYEN Price/Volume Stats
| Current price | $3.63 | 52-week high | $6.92 |
| Prev. close | $3.45 | 52-week low | $1.11 |
| Day low | $3.43 | Volume | 126,282 |
| Day high | $3.71 | Avg. volume | 402,733 |
| 50-day MA | $3.38 | Dividend yield | N/A |
| 200-day MA | $3.30 | Market Cap | 90.33M |
Eyenovia, Inc. (EYEN) Company Bio
Eyenovia, Inc., a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. It is developing MicroProst that has completed Phase III clinical trials for the treatment of chronic angle closure glaucoma; MicroStat that has completed Phase II clinical trials for the treatment of mydriasis; MicroTears for the treatment of dry eye; and MicroPine for the treatment of myopia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.
Loading social stream, please wait...